Statistics
Publications
1
Citations
65
H-Index
1
Active since
2022
Affiliations
Cleveland Clinic(Current)
Julie A. Shields is an author at Cleveland Clinic specializing in cancer cell signaling, epigenetic regulation in cancer, and promoter methylation.
Publications per year
2022–2022
1
1
VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
Julie A. Shields, Samuel R. Meier, Madhavi Bandi et al. · Cancer Research · 2022 · 65 citations · Full text
Life Sciences, Genetics, Oncology +17
1–1 of 1